Claas Wesseler
Harburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
80 Years of Lung Cancer - the Evolution of Diagnosis and Treatment
Journal: Pneumologie (Stuttgart, Germany)
Published: August 24, 2026
PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 08, 2025
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 12, 2024
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Journal: Pneumologie (Stuttgart, Germany)
Published: April 12, 2024
Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma
Journal: Pneumologie (Stuttgart, Germany)
Published: April 12, 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Journal: International journal of molecular sciences
Published: February 26, 2024
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions.
Journal: Future oncology (London, England)
Published: February 13, 2024
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).
Journal: JTO clinical and research reports
Published: September 21, 2023
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 24, 2023
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study.
Journal: Oncology research and treatment
Published: December 13, 2022
Is Dementia Associated with COVID-19 Mortality? A Multicenter Retrospective Cohort Study Conducted in 50 Hospitals in Germany.
Journal: Journal of Alzheimer's disease : JAD
Published: December 04, 2022
NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 23, 2022
Last Updated: 09/26/2026